跳至主要内容
临床试验/NCT03483363
NCT03483363终止4 期

Topical Antibiotic Irrigation (Gentamicin) in Prophylaxis of Midfacial Fracture Surgical Wounds

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2018年10月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
39
试验地点
1
主要终点
Number of Participants With Surgical Site Infection (SSI)

研究概览

简要总结

The purpose of this study is to evaluate the use of topical antibiotic irrigation (gentamycin) and its ability to reduce surgical site infections in midfacial fracture surgery compared to sterile normal saline (NS).

Previously, this study evaluated a different antibiotic, bacitracin, but in April of 2020 the study was modified to use gentamycin rather than bacitracin, after the FDA warning of the toxic side effects of bacitracin and because the hospital where the study was conducted removed bacitracin from its formulary.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients who are planned for open reduction internal fixation of midfacial fractures as part of standard of care
  • patients who are admitted to Memorial Hermann hospital at Texas Medical Center
  • able to sign their own consent

排除标准

  • infected surgical sites
  • allergies to bacitracin

研究组 & 干预措施

topical irrigation with the antibiotic plus intravenous (IV) prophylactic antibiotic

Experimental

Fractures will be topically irrigated with the topical antibiotic gentamicin (80mg diluted in 1L 0.9% normal saline) prior to closure.

[previously, this arm involve topical irrigation with bacitracin topical antibiotic (50,000 units), but in April of 2020 the study was modified to use gentamycin rather than bacitracin, after the FDA warning of the toxic side effects of bacitracin and because the hospital where the study was conducted removed bacitracin from its formulary.]

干预措施: topical irrigation with gentamicin (80mg diluted in 1L 0.9% normal saline) (Drug)

topical irrigation with the antibiotic plus intravenous (IV) prophylactic antibiotic

Experimental

Fractures will be topically irrigated with the topical antibiotic gentamicin (80mg diluted in 1L 0.9% normal saline) prior to closure.

[previously, this arm involve topical irrigation with bacitracin topical antibiotic (50,000 units), but in April of 2020 the study was modified to use gentamycin rather than bacitracin, after the FDA warning of the toxic side effects of bacitracin and because the hospital where the study was conducted removed bacitracin from its formulary.]

干预措施: intravenous (IV) prophylactic antibiotic (Drug)

topical irrigation with sterile normal saline (NS) plus intravenous (IV) prophylactic antibiotic

Active Comparator

Fractures will be irrigated with sterile normal saline prior to closure. All groups with receive standard parenteral (IV) prophylactic antibiotic.

干预措施: topical irrigation with sterile normal saline (NS) (Drug)

topical irrigation with sterile normal saline (NS) plus intravenous (IV) prophylactic antibiotic

Active Comparator

Fractures will be irrigated with sterile normal saline prior to closure. All groups with receive standard parenteral (IV) prophylactic antibiotic.

干预措施: intravenous (IV) prophylactic antibiotic (Drug)

结局指标

主要结局

Number of Participants With Surgical Site Infection (SSI)

时间窗: 8 weeks

Surgical site infections include evidence of infection: persistent swelling, fever, recurrent swelling, erythema, and purulent discharge.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nagi Demian

Professor

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验